Stock Price
105.60
Daily Change
0.45 0.43%
Monthly
1.20%
Yearly
46.75%
Q4 Forecast
103.34

Peers Price Chg Day Year Date
BASF 54.27 -0.18 -0.33% 24.84% Nov/13
DSM-Firmenich 105.60 0.45 0.43% 46.75% Nov/13
Givaudan 4,090.00 -1.00 -0.02% 20.40% Nov/13
International Flavors Fragrances 81.16 0.78 0.97% 23.19% Nov/13
Kerry 101.70 1.00 0.99% 29.22% Nov/13
Symrise 97.28 0.34 0.35% 34.92% Nov/13

Indexes Price Day Year Date
NL30 1141 0.84 0.07% 19.86% Nov/13

DSM-Firmenich AG traded at 105.60 this Friday November 13th, increasing 0.45 or 0.43 percent since the previous trading session. Looking back, over the last four weeks, DSM-Firmenich gained 1.20 percent. Over the last 12 months, its price rose by 46.75 percent. Looking ahead, we forecast DSM-Firmenich AG to be priced at 103.34 by the end of this quarter and at 96.85 in one year, according to Trading Economics global macro models projections and analysts expectations.

DSM-Firmenich AG, formerly Danube AG is a Switzerland based company, which is active in nutrition, health, and beauty industry. The Company operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The Company operates worldwide.